statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on...

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a company dedicated to ending obesity, today announced the pricing of an underwritten public offering of 14,406,508 shares of its...

Allurion Announces Launch of Offering of Common Stock and Warrants

Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of...

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average...

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the American Society for Metabolic and Bariatric Surgery Annual...

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Operating Officer. Effective June 3, 2024, Ojas...

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-powered weight loss coach, Coach Iris, to support...

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences: Jefferies Global Healthcare...

Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the 31st European Congress on Obesity (ECO) held in Venice, Italy...

Allurion Reports First Quarter 2024 Financial Results and Provides Business Update

Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a company dedicated to ending obesity, today announced its financial results for the first quarter ended March 31, 2024, and...

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.

Volume	152,535.00
52-Wk High	$9.00
52-Wk Low	$0.81

ALUR Allurion Technologies Inc

About

Feed

News

Earnings

Fundamentals